Editorial: What Are the Remaining Challenges before Blood-Based Biomarkers for Alzheimer's Disease Can Be Used in Clinical Practice?
- PMID: 36281660
- DOI: 10.14283/jpad.2022.89
Editorial: What Are the Remaining Challenges before Blood-Based Biomarkers for Alzheimer's Disease Can Be Used in Clinical Practice?
Conflict of interest statement
Dr. Bittner is a full time employee of F.Hoffmann-LaRoche and Genentech and owns stock options in F.Hoffmann-LaRoche.
Comment on
-
Blood Biomarkers from Research Use to Clinical Practice: What Must Be Done? A Report from the EU/US CTAD Task Force.J Prev Alzheimers Dis. 2022;9(4):569-579. doi: 10.14283/jpad.2022.85. J Prev Alzheimers Dis. 2022. PMID: 36281661 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical